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39% POST-1h (P < 0.01) but were unaffected POST-
1d (P > 0.05). In contrast, an increased number of Tregs 
expressing HLA-DR was observed at POST-1d (P < 0.01). 
Interleukin (IL)-1β, IL-6, IL-8 and IL-10 levels in the 
serum all increased POST-1h (P > 0.05) but returned to 
pre-exercise levels POST-1d. The suppressive cytokine, 
transforming growth factor-beta, was unaffected by the 
marathon (P > 0.05).
Conclusions These results suggest that Tregs do not play 
a major role in immune suppression in the early hours of 
recovery from a marathon. However, terminally differen-
tiated HLA-DR+ Tregs are mobilized the following day, 
which could represent a compensatory attempt by the host 
to restore immune homeostasis and limit excessive cell 
damage.
Keywords T-regulatory cells · Endurance exercise · 
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CV  Coefficient of variation
DMSO  Dimethyl sulfoxide
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Abstract 
Purpose T-regulatory cells (Tregs) are a sub-population 
of lymphocytes that act to suppress aberrant immune 
responses. We investigated changes in the numbers of naïve 
and terminally differentiated Tregs in the peripheral blood 
to establish their role in the immuno-suppressive response 
to prolonged exercise.
Methods Blood was drawn from seventeen experi-
enced runners (age 40 ± 12 years; height 1.75 ± 0.08 m; 
mass 71.4 ± 10.8 kg) before, ~1 h after (POST-1h), and 
on the day following the marathon (POST-1d). Tregs 
 (CD3+CD4+Foxp3+CD25++CD127−) were analysed in 
peripheral blood mononuclear cells using flow cytom-
etry. The markers CD45RA and HLA-DR were included 
to define naïve and terminally differentiated Tregs, 
respectively.
Results The absolute number of Tregs decreased (27%) 
POST-1h marathon (P < 0.001) but increased (21%) 
at POST-1d (P < 0.01). Naïve  CD45RA+ Tregs fell by 
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IL-10  Interleukin-10
INF-γ  Interferon-gamma
MCP-1  Monocyte chemoattractant protein 1
PBMC  Peripheral blood mononuclear cell
RBC  Red blood cells
RONS  Reactive oxygen and nitrogen species
TGF-β  Transforming growth factor-beta
TNF-α  Tumour necrosis factor-alpha
Tregs  T-regulatory cells
URTI  Upper respiratory tract infection
VEGF  Vascular endothelial growth factor
Introduction
It is well established that prolonged (>1.5 h), highly strenu-
ous bouts of exercise; a marathon or ultramarathon for 
example, can transiently perturb immune function, shift-
ing the balance towards a more immunosuppressive state 
(Gleeson 2007; Nieman 1997, 2007). This immune dys-
function can last for several days after exercise and is typi-
cally characterized by a decrease in the total number of 
circulating lymphocyte cells (Gleeson and Bishop 2005; 
Handzlik et al. 2013; Nieman et al. 2001), impaired acti-
vation and cytolytic function of natural killer (NK) cells 
(Gleeson and Bishop 2005; Nieman 1997; Nieman et al. 
1997), decreased secretion of immunoglobulin A (Glee-
son and Pyne 2015) and an altered type 1/type 2 T cell 
response, in favour of the latter (Martin et al. 2009).
This characteristic shift towards a more immunosup-
pressive cellular environment after endurance exercise 
could be driven by changes in the population of circulat-
ing T-regulatory cells (Tregs) (Gleeson et al. 2013; Hand-
zlik et al. 2013; Wang et al. 2012; Weinhold et al. 2016). 
Tregs, which can now be accurately identified by the 
expression of Fork-head box protein 3  (Foxp3+) intracel-
lularly, and  CD3+CD4+CD25++CD127− on the cell sur-
face (Weinhold et al. 2016), develop, classically, in the 
thymus (natural Tregs) but also in the periphery (inducible 
Tregs), and primarily function to prevent excessive immune 
responses to self-tissue (Belkaid 2007; Issazadeh-Navikas 
et al. 2012). Tregs maintain a healthy immune balance by 
suppressing the function and activity of a broad range of 
immune effector cells, including  CD8+ T cells, NK cells, 
and dendritic cells (Belkaid 2007; Issazadeh-Navikas et al. 
2012; Palomares et al. 2010; Sakaguchi et al. 2008). Hence, 
the proportion of Tregs in the cellular milieu is crucial to 
maintaining immune homeostasis; if they are produced in 
excess, they can inhibit the clearance of pathogens, leaving 
the host more susceptible to new viral or bacterial infec-
tions (Belkaid 2007; Liston and Gray 2014). These obser-
vations have led to the suggestion that changes in the circu-
lating pool of Tregs might help to explain, at least in part, 
the increased incidence of upper respiratory tract infections 
(URTI) reported after prolonged, strenuous exercise (Hand-
zlik et al. 2013; Nieman 1997; Wang et al. 2012).
However, a possible modulatory role for Tregs in acute 
exercise-induced immunosuppression has only been con-
sidered by a limited number of human studies. In addition, 
the few that have been conducted have come to contrast-
ing conclusions, with some studies suggesting exercise 
increases the number of circulating Tregs (Wilson et al. 
2009; Krüger et al. 2016), decreases circulating Tregs 
(Perry et al. 2013) or has no effect on circulating Tregs 
(Handzlik et al. 2013; Rehm et al. 2013). Interestingly, the 
findings of Perry et al. (2013), that exercise decreases the 
number of circulating Tregs, runs counter to the supposi-
tion that Tregs increase after exercise and function to mod-
ulate the immuno-suppressive response (Handzlik et al. 
2013; Wang et al. 2012).
In addition to the equivocal findings to date, there are 
also a number of limitations with these studies that need to 
be addressed. First, only one of these studies (Rehm et al. 
2013) defined Tregs by the expression of  CD25++/bright 
cells in conjunction with  FoxP3+ cells, which is required 
to accurately distinguish those with high immunosuppres-
sive activity (Fountoulakis et al. 2008). Second, none of 
the studies to date have measured changes in Tregs in the 
3–72 h after exercise, the so-called ‘open window’ period 
when immune suppression is supposed to be heightened 
(Nieman 2007). Given these limitations, the primary aim 
of the present study was to examine peripheral changes in 
 CD3+CD4+FoxP3+CD25++CD127− Tregs before, ~1 h, 
and the day following a marathon. We also examined, for 
the first time after prolonged, endurance exercise, Tregs 
expressing CD45RA, to give an indication of the naïve 
Tregs population (Valmori et al. 2005), and Tregs express-
ing human leukocyte antigen (HLA)-DR, to give an indi-
cation of their differentiation status (Costantino et al. 
2008). The changes in circulating Treg cell populations 
were measured alongside a range of cytokines involved in 
the immune response to prolonged exercise, and we were 
especially interested in IL-10 and transforming growth 
factor-beta (TGF-β), given their relationship with Treg 
cell function. We hypothesized that Tregs, including those 
expressing HLA-DR, would increase after the marathon, 
as would the immunosuppressive cytokines IL-10 and 
TGF-β.
Methods
Participants
Seventeen runners taking part in the Druridge Bay 
Marathon, Northumberland, UK, volunteered for this 
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investigation. A summary of their physical characteristics 
and training history is displayed in Table 1. Samples were 
obtained from a sub-group of participants taking part in a 
larger study (Clifford et al. 2016); only those whose sam-
ples were collected before mid-day were included to limit 
diurnal variation. The participants completed a health-
screening questionnaire to assess the eligibility for the 
study and were excluded if they had any cardiovascular 
complications, a recent (<3 months) musculoskeletal injury 
or were receiving prescribed anti-inflammatory medica-
tions other than for asthma. Of the female participants still 
menstruating, the marathon took place during the early/mid 
luteal phase. The environmental conditions on the day of 
the race have been described before (Clifford et al. 2016). 
Briefly, at the start of the race air temperature was 3.8 °C; 
humidity 82%; barometric pressure 1013 hpa and wind 
speed 9 km/h; the weather remained dry throughout and the 
temp increased to 8.1 °C towards the end of the race. All 
procedures were carried out as per the guidelines set out 
in the Declaration of Helsinki. The study received ethical 
approval from the Faculty of Health and Life Sciences Eth-
ics Committee at Northumbria University. All participants 
provided written informed consent prior to participation.
Blood sampling
Blood samples were obtained from a branch of the basilica 
vein at the antecubital fossa on three occasions: the week 
leading up to the marathon (PRE), ~1 h post-marathon 
(POST-1h), and the day following the marathon (POST-1d). 
At all-time points, blood was drawn into a 10 ml vacutainer 
for serum and 4 ml and 10 ml vacutainers coated with di-
potassium ethylene diamine tetra-acetic acid (EDTA). The 
serum vacutainer was allowed to stand and clot for 30 min 
before being centrifuged at 3000g for 10 min to separate 
the supernatant. This was subsequently stored in aliquots at 
−80 °C and only thawed in the morning of the analysis. 
The 4 ml EDTA vacutainer was transported to a local hos-
pital for haematological analysis. The 10 ml EDTA vacu-
tainer was transported to the Institute of Cellular Medicine, 
Newcastle University, for peripheral blood mononuclear 
cell (PBMC) isolation and flow cytometric analysis (see 
sections below).
Haematological and cytokine analysis
Haemoglobin, haematocrit, red blood cells (RBC), leu-
kocytes and lymphocyte counts were measured in whole 
blood using an automated haematology system (Sysmex 
XE-2100, IL, USA). According to data provided by the 
laboratory, the coefficient of variation (CV) for these pro-
cedures are typically <10%. Haemoglobin and haemato-
crit were used to calculate pre–post marathon changes in 
plasma volume according to the equations of Dill and Cos-
till (1974). Interleukin (IL)-1ra, Il-1β, IL-2, IL-4, IL-6, 
IL-8, IL-10, TNF-α and IFN-γ were measured in serum 
as part of a multiplex sandwich chemiluminescent immu-
noassay kit (Evidence Investigator, Randox Laboratories, 
Northern Ireland, UK). Inter and intra assay CVs for this 
analysis was <5%. TGF-β was analysed in serum using a 
commercially available ELISA kit (R&D Systems, Minne-
apolis, USA). Intra-assay CV for this analysis was <15%.
Peripheral blood mononuclear cell isolation
Peripheral blood mononuclear cells were purified by den-
sity gradient centrifugation. Blood samples collected from 
10 ml EDTA vacutainers were added to a leucosep tubes 
(Grenier bio-one) and centrifuged for 10 min at 900g. 
PBMCs were recovered from the interphase and washed 
at 600 and 250g for 7 min. Cell washes were carried out 
with HBSS cell wash media (Hanks Balanced Salt Solution 
(Lonza) supplemented with 10% fetal bovine serum (FBS) 
(Life Technologies BRL), and cell pellet re-suspended in 
appropriate medium unless stated otherwise.
Cryopreservation and thawing of cells
Peripheral blood mononuclear cell pellets were first re-sus-
pended in FBS, and then an equal volume of FBS +20% 
DMSO (Sigma-Aldrich) was added dropwise to the cell 
suspensions (final concentration – FBS + 10% DMSO). 
PBMC suspensions were split between two cryovials, 
then placed in a room temperature cool cell and stored at 
−80 °C. This ensures freezing occurs at a rate less than 
1 °C/min. For thawing, cryovials were placed in a 37 °C 
Table 1  Participants physical characteristics, training history and 
marathon race data
Values are mean ± SD
Physical characteristics
 Age (years) 40 ± 12
 Sex (M/F) 12/5
 Height (m) 1.75 ± 0.08
 Mass (kg) 71.4 ± 10.8
Training history
 No. of years running 11 ± 10
 Average training distance (miles/week) 34 ± 11
 Longest training run for marathon (miles) 21 ± 2
 No. of previous marathons finished 16 ± 20
Marathon race
 Marathon finish time (hh:min:ss) 04:03:00 ± 00:48:09
 Pre–post change in body mass (kg) 1.4 ± 1.0
 Pre–post plasma volume change −2.3 ± 4.1
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water bath for 10 min. The PBMC suspension was then 
transferred to a 30 ml universal tube, and 10 ml of pre-
warmed thawing medium (RPMI-1640 + supplemented 
with 10% FBS) was added slowly, at a rate of <1 ml/5 s. 
The cells were washed twice at room temperature at 400g 
for 7 min, and resuspended in PBS.
Flow cytometry analysis
Flow cytometry analysis is expressed as changes in the  % 
of total lymphocytes and the absolute number of cells per 
μl of peripheral blood. Total Tregs and Treg cell subpopu-
lations (‘naïve’  CD45RA+ and ‘mature’ HLA-DR+) are 
also expressed as a % of total  CD3+CD4+ cells. The gat-
ing strategy used to define  CD3+CD4+ cells and Tregs is 
displayed in Fig. 1. Briefly, in a sequential fashion, gating 
was performed to exclude debris; followed by gating on the 
total lymphocyte population in the FSC/SSC plot. Lym-
phocytes co-expressing  CD3+CD4+ were then gated on to 
determine the % of  CD3+CD4+ cells in the total lympho-
cyte population. For identification of Tregs, the  CD3+CD4+ 
cell population was gated on by initially plotting CD25 
against FoxP3 to determine the  CD25++FoxP3+ popula-
tion, followed by gating on the  CD127− population, giv-
ing  CD3+CD4+Foxp3+CD25++CD127− Tregs. Tregs were 
subsequently gated for CD45RA and HLA-DR expression. 
Cells expressed as a % of total lymphocytes and % of total 
 CD3+CD4+ cells were calculated by the FlowJo analysis 
software following the above gating strategy.
T‑regulatory cell analysis
Thawed PBMC were stained with viability dye Zombie 
NIR (Biolegend) at room temperature for 15 min. Cells 
were washed, resuspended in blocking buffer [PBS + 9% 
human IgG (Sigma, Poole, UK) + 27% mouse serum 
(Sigma)] and stained with following anti-human monoclo-
nal antibody cocktail: anti-CD3-Alexa Fluor 488 (UCHT1); 
anti-CD4-V500 (RPA-T4); anti-CD25-APC (M-A251); 
anti-CD45RA-Alexa Fluor 700 (HI100); anti-CD127-
PE-Cy7 (HIL-7R-M2); anti-HLA-DR-V450 (L243) (all 
BD Biosciences, CA, USA). After incubation at 4 °C for 
20 min, cells were fixed and permeabilized using appro-
priate buffers (FoxP3 Fixation/Permeabilization Concen-
trate and diluent kit; eBioscience Ltd, Hatfield, UK) then 
resuspended in perm/wash buffer (BD Biosciences). Intra-
cellular staining of Fox-P3 was achieved using anti-FoxP3-
PE (236A/E7, BD Biosciences). Cells were incubated at 
4 °C for 30 min then washed and resuspended in fluores-
cence-activated cell sorting (FACS) buffer (PBS + 0.5% 
BSA + 0.01% sodium azide). Data were acquired on a 
LSR Fortessa X20 (BD Biosciences) and analysed using 
FlowJo Version 8.8.7 (Treestar, Ashland, OR, USA).
Data analysis
All data were analysed using GraphPad Prism (GraphPad 
Software Inc., CA, USA) and expressed as mean ± SD 
unless stated otherwise. Paired t tests were used to ana-
lyse pre–post marathon changes in mass and plasma vol-
ume (PV). Time course changes from PRE to POST-1h 
or POST-1d for cytokine, haematological and Treg cell 
variables were adjusted for PV changes according to the 
methods of Dill and Costill (1974) and subsequently ana-
lysed using a one-way analysis of variance (ANOVA), 
with Bonferroni corrections applied for multiple compari-
sons. Cohen’s d effect sizes (ES) were calculated with the 
magnitude of effects considered small (0.2–0.49), medium 
(0.5–0.79) and large (≥0.8). Statistical significance was set 
at P < 0.05 prior to analyses.
Results
Haematology
Changes in haematological parameters induced by the 
marathon are presented in Table 2. Total blood lympho-
cyte concentrations dropped by 20% POST-1h (P = 0.02; 
ES = 0.72) but had returned to baseline by POST-1d 
(P > 0.05; ES = 0.46). Whole blood leukocyte concentra-
tions were 160 and 21% higher than PRE values at POST-
1h and POST-1d, respectively (P < 0.01). Both neutrophils 
and monocytes were above PRE concentrations at POST-1h 
and POST-1d (P < 0.001). Eosinophils fell by 68% POST-
1h (P < 0.01; ES = 1.24) but returned to PRE values by 
POST-1d (P > 0.05; ES = 0.17). Basophil counts were 
elevated above PRE at POST-1h (P = 0.02; ES = 0.43) 
but not significantly at POST-1d (P > 0.05). In summary, 
while lymphocytes and eosinophils fell below baseline lev-
els after the marathon, phagocytic leukocytes (neutrophils 
and monocytes) were elevated post-marathon and remained 
elevated the following day.
Cytokines and growth factors
A number of cytokines and growth factors were meas-
ured to determine their role in the inflammatory response 
after the marathon, and if changes in these parameters 
were associated with changes in Treg cell activity; these 
results are displayed in Table 3. At POST-1h, there was a 
large increase in IL-6 (3062%; ES = 2.96), IL-8 (136%; 
ES = 1.48) and IL-10 (2022%; ES = 2.14) (P < 0.01), and 
a moderate increase in TNF-α (15%; ES = 0.39) and IL-1β 
(62%; ES = 0.87) (P < 0.05). All cytokines had returned 
to PRE levels by POST-1d (P > 0.05). IL-1ra, IL-1, IFN-γ, 
IL-2, IL-4, TGF-β did not rise appreciably above PRE at 
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Fig. 1  Gating strategy to define Treg subsets. A Gating was per-
formed to exclude debris (a), doublets (b), red blood cells (c) and 
dead cells (d) using time during acquisition, forward and side scat-
ter properties and viability dye zombie NIR. Final gating is on the 
lymphocyte population (e). B Gating strategy to define Treg sub-
sets within the  CD3+CD4+ population (f):  CD25++Foxp3+ (g) and 
 CD127− total Tregs (h);  CD45RA+ Tregs (i) and HLA-DR+ Tregs (j)
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any time point after the marathon (P > 0.05). Therefore, the 
marathon stimulated only a transient cytokine response that 
was not evident the day after the marathon, and thus, these 
cytokines did not seem to be associated with the elevated 
Treg cell activity at this time point (see below).
CD3+CD4+ lymphocytes
Cells expressing  CD3+CD4+ were measured to give an 
indication of overall T helper-cell mobilization within the 
total lymphocyte population. The % of  CD3+CD4+ cells in 
the total lymphocyte pool was not significantly increased at 
POST-1h or POST-1d (P > 0.05; Fig. 2a). In contrast, the 
absolute numbers of  CD3+CD4+ cells were 14% higher at 
POST-1d (P = 0.01; ES = 0.59) but unchanged at POST-
1h compared to PRE (P > 0.05; ES = 0.18; Fig. 2b). Thus, 
while the absolute number of circulating  CD3+CD4+ 
increased the day after, they were unchanged in the imme-
diate hours following the marathon.
Treg cell subpopulations
Because Tregs are believed to play an important role in 
immunosuppression, and thus, might heighten UTRI 
risk after long duration exercise, we analysed periph-
eral changes in these cells up to 1 day following the 
marathon. Changes in the population of all Tregs subsets 
analysed are presented in Fig. 3. The % of total Tregs 
 (CD3+CD4+FoxP3+CD25++CD127−) in total lympho-
cytes did not change POST-1h (P = 0.08; ES = 0.35) but 
increased at POST-1d (P = 0.02; ES = 0.42; Fig. 3a). 
There was a decrease in the % of Tregs in  CD4+ cells 
POST-1h (P = 0.01; ES = 0.62) but no change from PRE at 
POST-1d (P = 0.13; ES = 0.30; Fig. 3b). The mean num-
ber of absolute Tregs at PRE was 21.1 ± 11.8 (cells/µl). At 
POST, cell numbers decreased to 15.3 ± 11.3 (P = 0.01; 
ES = 0.50); but at POST-1 increased to 26.6 ± 14.7 
(P = 0.01; ES = 0.41; Fig. 3c). Thus, the number of Tregs 
decreased ~1 h after the marathon before rebounding, and 
increasing above pre-exercise values the following day.
Tregs expressing  CD45RA+ were analysed to character-
ize changes in the naive Treg cell population induced by 
the marathon. The % of  CD45RA+ Tregs in total lympho-
cytes (Fig. 3d) and % in  CD4+ cells (Fig. 3e) decreased at 
POST-1h (P = 0.01; ES = 0.43 and P = 0.01; ES = 0.57, 
respectively) but were not different to PRE levels by POST-
1d (P > 0.05). A similar pattern was observed for absolute 
cell counts of  CD45RA+ Tregs, which decreased by 39% 
POST-1h (P = 0.01; ES = 0.48) but were similar to PRE 
at POST-1d (P > 0.05; ES = 0.03; Fig. 3f). These data indi-
cate that the naïve Treg cell population decreased in the 
immediate hours after the marathon but was restored to 
pre-exercise levels by the following day.
We analysed Tregs cells expressing the HLA-DR marker, 
which is purported to represent a distinct and mature pop-
ulation of Tregs, displaying enhanced suppressive activ-
ity and mainly acting in a cell contact-dependent manner 
(Costantino et al. 2008). We found that the % of HLA-DR+ 
Tregs in total lymphocytes was unchanged at POST-1h 
(P > 0.05; ES = 0.03) but increased from 0.33 ± 0.11 to 
0.45 ± 0.11 at POST-1 (P = 0.01; ES = 0.95; Fig. 3g). The 
proportion of HLA-DR+ Tregs within the  CD3+CD4+ pop-
ulation were also higher than PRE at POST-1d (P = 0.01; 
ES = 0.75; Fig. 3h). Similarly, the mean number of abso-
lute HLA-DR+ Tregs was unchanged POST-1h (P > 0.05; 
ES = 0.29) but increased by 42% at POST-1d (P = 0.01; 
ES = 0.88; Fig. 3i). Therefore, the number of mature, 
terminally differentiated HLA-DR+ Tregs, remained 
unchanged in the immediate hours post-marathon, but were 
Table 2  Haematology before and after the marathon
One-way ANOVA was used to test for time differences
PRE before the marathon, POST-1h 1 h after the marathon, POST-1d 
1 day after the marathon
* Different from pre-race (P < 0.05)
Biomarker PRE POST-1h POST-1d
Lymphocytes  (109 cells/l) 1.99 ± 0.54 1.61 ± 0.50* 2.26 ± 0.61
Leukocytes  (109 cells/l) 5.5 ± 1.1 14.3 ± 2.8* 6.6 ± 1.0*
Neutrophils  (109 cells/l) 2.8 ± 0.8 11.5 ± 2.6* 3.6 ± 1.2*
Monocytes  (109 cells/l) 0.5 ± 0.1 1.0 ± 0.4* 0.6 ± 0.2*
Eosinophils  (109 cells/l) 0.19 ± 0.13 0.06 ± 0.07* 0.16 ± 0.11
Basophils  (109 cells/l) 0.03 ± 0.01 0.04 ± 0.02* 0.04 ± 0.01
Table 3  Cytokine levels is serum before and after the marathon
PRE before the marathon, POST-1h 1 h after the marathon, POST-1d 
1 day after the marathon, IL interleukin, ra receptor antagonist, TNF-
α tumour necrosis factor-alpha, TGF-β transforming growth factor-
beta, IFN-γ interferon-gamma
* Different from pre-race (P < 0.05)
Biomarker (pg/ml) PRE POST-1h POST-1d
IL-1ra 0.43 ± 0.34 0.37 ± 0.23 0.35 ± 20
Il-1β 1.64 ± 0.99 2.66 ± 1.32* 1.86 ± 0.79
IL-2 3.9 ± 4.0 5.9 ± 8.8 3.8 ± 3.6
IL-4 2.2 ± 0.6 2.1 ± 0.5 2.4 ± 0.7
IL-6 1.0 ± 0.5 33.1 ± 21.1* 1.7 ± 1.2
IL-8 8.7 ± 5.7 20.6 ± 10.3* 7.9 ± 5.0
IL-10 1.1 ± 0.5 23.5 ± 20.4* 0.9 ± 0.2
TNF-α 2.9 ± 1.1 3.4 ± 1.1* 2.9 ± 1.1
TGF-β 19010 ± 9876 20907 ± 8991 17876 ± 9479
IFN-γ 0.55 ± 0.70 0.44 ± 0.62 0.46 ± 0.58
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significantly and substantially increased the day following 
the marathon.
Discussion
In the present study, we evaluated changes in circulat-
ing Tregs before and up to 1 day following a marathon. 
We found that: (1) Tregs exhibited a biphasic response, 
whereby post-marathon, they decreased, but the following 
day, they rebounded, and increased above pre-marathon 
levels, and; (2) the number of HLA-DR+ and, therefore, 
mature Tregs, significantly increased the day after the 
marathon.
The finding that Tregs decreased below pre-marathon 
levels ~1 h post are in agreement with those of Perry et al. 
(2013), who also found that Tregs decreased after a mara-
thon or ironman triathlon race. Yet they are in contrast to 
those of Wilson et al. (2009) and Krüger et al. (2016) who 
reported that Tregs increased after high intensity interval 
swimming and cycling exercise, respectively. Others found 
no changes in Treg cell numbers after 30 or 60 min of sub-
maximal cycling exercise (Handzlik et al. 2013; Krüger 
et al. 2016). The discrepancy in findings between these 
studies and ours could simply be due to the different meth-
ods used to quantify and define Tregs. However, another 
possible explanation is related to the different types and 
duration of exercise. In ours and the study of Perry et al. 
(2013), in which the exercise stimulus was much longer in 
duration (≥3 h), Tregs decreased after exercise, whereas 
in the studies that were short duration (≤30 min), but 
performed at a high intensity, Tregs increased (Krüger et al. 
2016; Wilson et al. 2009). In contrast, studies in which 
the exercise stimulus was of a moderate intensity (~70% 
VO2max) had no effect on circulating Treg cell numbers 
(Handzlik et al. 2013; Krüger et al. 2016). Taken together, 
it seems that Tregs do not play a major role in suppress-
ing the immune system after moderate intensity exercise, or 
prolonged endurance exercise—at least in the early stages 
of recovery—but may after short duration, high intensity 
exercise.
A possible explanation for the decrease in Tregs is that 
the marathon stimulated cell death via apoptosis. Although 
Treg cell death was not measured in this study, a recent 
study (Krüger et al. 2016) found that continuous aerobic 
exercise (30 min of cycling at 70% VO2max) elicits apop-
tosis in peripheral Tregs, which lends some support to this 
idea. Exercise-induced Treg cell apoptosis would also be 
wholly consistent with the effects of aerobic exercise on 
other T-cell sub-populations (Krüger et al. 2016; Navalta 
et al. 2013). Alternatively, it is also important to consider 
that the decrease in circulating Tregs simply reflects the 
fact that they were rapidly distributed to other tissues after 
the marathon, as suggested with other T-cells populations 
(Krüger et al. 2016; Krüger et al. 2008). Further research is 
needed to determine the biochemical processes to explain 
the decrease in Tregs after the marathon and also the clini-
cal significance of this finding.
The day after the marathon, there was a significant 
increase in  CD3+CD4+ cells, which could represent mobi-
lization of the T-cell population (Gleeson and Bishop 2005; 
Walsh et al. 2011). Perhaps of most importance, there 
Fig. 2  CD3+CD4+ cells PRE 
(before the marathon); POST-1h 
(1 h after the marathon); POST-
1d (1 day after the marathon). a 
Percentage of  CD3+CD4+ cells 
in total lymphocytes, b total 
 CD3+CD4+ cells (number per 
µl in blood). Asterisk denotes 
higher than PRE (P < 0.05); 
one-way ANOVA was used to 
test for time differences
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Fig. 3  T-regulatory (Treg) cells PRE (before the marathon); POST-
1h (1 h after the marathon); POST-1d (1 day after the marathon). a 
Percentage of Tregs in total lymphocytes, b percentage of Tregs 
in  CD3+CD4+ cells, c total Tregs (number per µl in blood), d per-
centage of  CD45RA+ Tregs in total lymphocytes, e percentage of 
 CD45RA+ Tregs in  CD3+CD4+ cells, f total  CD45RA+ Tregs (num-
ber per µl in blood), g percentage of  HLADR+ Tregs in total lym-
phocytes, h percentage of  HLADR+ Tregs in  CD3+CD4+ cells, 
i total  HLADR+ Tregs (number per µl in blood). Hash symbol 
denotes lower than PRE (P < 0.05); asterisk denotes higher than PRE 
(P < 0.05). One-way ANOVA was used to test for time differences
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was a parallel increase in the number of Tregs expressing 
HLA-DR, representing terminally differentiated, mature, 
Tregs. The fact that the proportion of HLA-DR+ Tregs 
in the  CD3+CD4+ and total lymphocyte populations also 
increased suggests that these cells might have been prefer-
entially expanded/mobilized within the whole T-cell pool. 
Importantly, these findings not only provide the first evi-
dence that Treg cell numbers are increased the day after 
a marathon, but that in particular the number of mature 
Tregs, known to have enhanced suppressive activity, have 
gone up. The mechanism by which HLA-DR+ Tregs are 
preferentially mobilised 1 day after a marathon remains to 
be investigated.
The reason for the delayed Treg cell response after the 
marathon is unclear, but since the main function of Tregs 
is to terminate T-cell effector responses and, broadly, gen-
eral suppression of the immune system (Issazadeh-Navikas 
et al. 2012), it could be that this response signifies a com-
pensatory attempt to limit excessive cell damage, possibly 
that caused during the reconstruction of dysfunctional cells. 
Indeed, it is well established that strenuous physical exer-
cise stimulates a sequential process of inflammation and 
regeneration that first involves the destruction of damaged 
or necrotic cells (Chazaud 2016; Tidball and Villalta 2010). 
It would be reasonable to assume that the accumulation of 
Tregs in the circulation was in response to such effects, and 
that perhaps these cells were being mobilized for distribu-
tion to various tissues for reparative processes, the most 
obvious being skeletal muscle. Burzyn et al. (2013) found 
that Tregs accumulate in damaged skeletal muscle of mice, 
lending some support to this idea. The authors proposed 
that their role might be in orchestrating the characteristic 
switch from a pro-inflammatory to anti-inflammatory envi-
ronment, which promotes satellite cell proliferation and 
muscle healing. This suggests that Tregs increased the day 
after the marathon to restore normal immune function.
Post-marathon, there was a decrease in the absolute 
number of  CD45RA+ Tregs and their proportion in the 
total lymphocyte and  CD3+CD4+ populations. This is the 
first study to measure Tregs expressing CD45RA after a 
marathon, but these findings are consistent with a previ-
ous study that, although they did not specifically define 
 CD45RA+ Tregs, they did find  CD4+  CD45RA+ cells 
(and thus presumably the whole T-cell pool) to increase 
after high intensity running exercise (Simpson et al. 2007). 
The significance of our finding is unclear, and it is possi-
ble that the decrease in Tregs expressing CD45RA is just a 
reflection of the decrease in the total Treg cell population. 
Alternatively, given that the expression of CD45RA cells is 
believed to represent an immunologically naïve population 
of T-cells, it is likely that the decrease in  CD45RA+ signi-
fies a switch from naïve Tregs to memory/activated Tregs 
expressing the CD45RO variant (Seddiki et al. 2006).
The leukocyte response followed a similar pattern to that 
reported for previous marathon studies (Nieman et al. 2001; 
Shanely et al. 2014; Suzuki et al. 2000). The increase in 
total leukocytes, especially the neutrophilia and monocyto-
sis has consistently been observed after marathons (Nieman 
et al. 2001; Shanely et al. 2014; Suzuki et al. 2000) and 
is probably due to the secretion of cytokines, chemokines 
and stress hormones during and in the immediate hours 
after the race (Slattery et al. 2015; Nieman et al. 2001). The 
continued elevation in neutrophils and monocytes the fol-
lowing day might be a response to any cardiac or skeletal 
muscle damage resulting from the marathon (Hikida et al. 
1983; Paulsen et al. 2010; Whyte 2008).
As in the majority of previous studies, we observed a 
significant increase in IL-6, IL-8 and IL-10, after the mara-
thon (Shanely et al. 2014; Suzuki et al. 2000, 2003), which 
further confirms the important modulatory role of these 
cytokines in the early immune response to endurance exer-
cise. Interestingly, none of the cytokines measured in this 
study were upregulated the day after the marathon. In this 
regard, the most surprising finding was that TGF-β, a sup-
pressive cytokine produced by Tregs, remained unchanged 
after the marathon. Although not a consistent finding 
(Suzuki et al. 2000), two studies reported increased TGF- 
β in response to a marathon (Perry et al. 2013; Toft et al. 
2000) and, given its relationship with Tregs, we anticipated 
TGF-β and Tregs to follow a similar pattern of change 
after the marathon. Exactly why TGF-β was unchanged in 
the present study, but was in others (Perry et al. 2013; Toft 
et al. 2000) is unclear. Differences in study design, includ-
ing the timing of measurements, exercise intensity, par-
ticipants, and analytical procedures are all feasible expla-
nations. It is also possible that had we analysed just active 
TGF-β, as opposed to total TGF-β (therefore, excluding 
latent TGF- β), then we would have seen increases above 
baseline following the marathon. Nonetheless, our findings 
suggest that the increase in mature HLA-DR+ Tregs was 
largely independent of total TGF-β (and IL-10) production 
after the marathon, which is in keeping with this Treg pop-
ulation primarily inducing its suppressive effects via cell-
contact dependent mechanisms (Baecher-Allan et al. 2006; 
Costantino et al. 2008).
It is important to acknowledge the limitations of this 
study. First, as our study was performed in endurance 
trained athletes, these findings are unlikely to be general-
izable to exercise naïve individuals or even athletes unac-
customed to endurance exercise. Another important limi-
tation of this study is that our analysis was limited to the 
circulation, and thus, we cannot exclude the possibility that 
Treg cell activation displays a different pattern of change in 
other tissues after endurance exercise. The biological rel-
evance of the changes observed in this study also requires 
investigation.
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In conclusion, our results show that the Treg cell 
response to a marathon is biphasic; after initially decreas-
ing in the early stages of recovery, they increase the follow-
ing day, presumably to limit excessive cell damage. These 
findings suggest that, contrary to recent suggestions (Hand-
zlik et al. 2013; Wang et al. 2012; Weinhold et al. 2016), 
Tregs do not appear to be major contributors to the imme-
diate immuno-suppressive effect of prolonged, strenuous 
exercise. Additionally, they also suggest that Tregs might 
play a key role in limiting cell dysfunction arising from 
exercise-related inflammation and perhaps they could be 
manipulated (e.g. via dietary changes; Issazadeh-Navikas 
et al. 2012) to promote the restoration of cell homeostasis 
after exercise.
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